Oct 29, 2020 / 02:00PM GMT
Operator
Hello, and good morning, everyone. Thanks for joining us for B. Riley Research Hosted Liver Disease Therapeutics Day, where we have exciting 5 panel discussions comprising of over 15 companies lined up to review the exciting therapeutics innovation across a number of orphan and large prevalence disease. (Operator Instructions) If you have any questions feel free to send them to our host, Mayank Mamtani, at [email protected].
With that, Mayank, the floor is all yours.
Mayank Mamtani - B. Riley Securities, Inc., Research Division - Research Analyst
Thank you, Kevin. Good morning, everyone. We welcome you to our Virtual Liver Disease Therapeutics Day 2020. I hope everyone is doing well and staying safe. We have an exciting new -- exciting few hours of panel discussions featuring some of the most exciting R&D work happening at a number of innovative biotech companies across a number of liver diseases that we'll speak to.
I'm grateful to management team for making time, Dr. Stephen Harrison in particular for joining the 2 NASH panels. We
Arcturus Therapeutics Holdings Inc. - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
